BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Stealth BioTherapeutics to Report Third Quarter Financial Results on Thursday, November 11

  Stealth BioTherapeutics Corp today announced that it will report third quarter 2021 financial results on Thursday, November 11 , before the market opens.

  November 4, 2021

   · 

  2 min read
• Business

  Biohaven To Report Third Quarter 2021 Financial Results And Recent Business Developments On November 9, 2021

  Biohaven Pharmaceutical Holding Company Ltd. will hold its upcoming third quarter 2021 earnings call and webcast, reporting financial results for the quarter ended September 30, 2021.

  November 4, 2021

   · 

  2 min read
• Drug Development

  Soligenix Announces Publication Demonstrating Enduring Protection of its Thermostable RiVax® Vaccine

  Soligenix, Inc. announced today publication of pre-clinical immunogenicity studies for RiVax® (heat stable ricin toxin vaccine) demonstrating enduring protection for at least 12 months post-vaccination.

  November 4, 2021

   · 

  11 min read
• Business

  BridgeBio Pharma Reports Third Quarter 2021 Financial Results and Business Update

  BridgeBio Pharma, Inc. today reported its financial results for the third quarter ended September 30, 2021 and provided an update on the Company’s operations.

  November 4, 2021

   · 

  17 min read
• Pharm Country

  Motion Acquisition Corp. and DocGo Announce Upcoming Presentation at the Credit Suisse Virtual Healthcare Conference

  Motion Acquisition Corp. and its merger partner Ambulnz , Inc., dba DocGo announced today that DocGo CEO Stan Vashovsky will present at the Credit Suisse Virtual Healthcare Conference

  November 4, 2021

   · 

  5 min read
• MINDCURE Provides Update on Studies and Clinical Trials

  Mind Cure Health Inc. is pleased to provide an operational progress update on the strategic initiatives of its operating segments

  November 4, 2021

   · 

  7 min read
• Business

  Atara Biotherapeutics Announces Third Quarter 2021 Financial Results and Operational Progress

  Atara Biotherapeutics, Inc. today reported financial results for the third quarter 2021, recent business highlights and key catalysts over the next several months.

  November 4, 2021

   · 

  18 min read
• Drug Development

  XOMA Earns $35 Million Milestone Payment as Anti-TGFβ Antibody Enters Phase 3 Clinical Study in Metastatic Pancreatic Cancer

  XOMA Corporation (Nasdaq: XOMA) announced today NIS793, an anti-TGFβ monoclonal antibody licensed from the Company, has advanced to the Phase 3 development stage, triggering a $35 million milestone payment from Novartis.

  November 4, 2021

   · 

  5 min read
• Business

  Orchard Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Business Updates

  Orchard Therapeutics today reported financial results for the quarter ended September 30, 2021, as well as recent business updates and upcoming milestones.

  November 4, 2021

   · 

  18 min read
• Business

  Atea Pharmaceuticals to Host Third Quarter Financial Results Conference Call on November 11, 2021

  Atea Pharmaceuticals, Inc. today announced that it will host a live conference call and audio webcast on Thursday, November 11, 2021 at 4:30 p.m. ET to report financial results for the third quarter ended September 30, 2021, and to provide a clinical and corporate update.

  November 4, 2021

   · 

  1 min read